A Study of Novel Anti-cancer Agents in Patients With Previously Untreated NSCLC
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Chih-Hsin Yang, MD
National Taiwan University Hospital
Principal Investigator - Sandip Patel, MD
UCSD Morres Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
41 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Research Site
Salzburg, Austria
- Research Site
Vienna, Austria
- Research Site
Edegem, Belgium
- Research Site
Bialystok, Poland
- Research Site
Bydgoszcz, Poland
- Research Site
Gdansk, Poland
- Research Site
Grudziądz, Poland
- Research Site
Lodz, Poland
- Research Site
Olsztyn, Poland
- Research Site
Tomaszów Mazowiecki, Poland
- Research Site
Warsaw, Poland
- Research Site
Wroclaw, Poland
- Research Site
Krasnoyarsk, Russia
- Research Site
Moscow, Russia
- Research Site
Saint Petersburg, Russia
- Research Site
Saint Petersburg, Russia
- Research Site
Cheongju-si, South Korea
- Research Site
Seoul, South Korea
- Research Site
Seoul, South Korea
- Research Site
Seoul, South Korea
- Research Site
Seoul, South Korea
- Research Site
Barcelona, Spain
- Research Site
Barcelona, Spain
- Research Site
Madrid, Spain
- Research Site
Madrid, Spain
- Research Site
Seville, Spain
- Research Site
Kaohsiung City, Taiwan
- Research Site
Taichung, Taiwan
- Research Site
Taichung, Taiwan
- Research Site
Tainan, Taiwan
- Research Site
Taipei, Taiwan
- Research Site
Taipei, Taiwan
- Research Site
Taipei, Taiwan
- Research Site
Taoyuan, Taiwan
- Research Site
Bangkok, Thailand
- Research Site
Bangkok, Thailand
- Research Site
Chiang Mai, Thailand
- Research Site
Hat Yai, Thailand
- Research Site
Iowa City, Iowa, United States
- Research Site
Pittsburgh, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 27 Dec 2018
- Primary completion
- 23 May 2023
- Completion
- 1 Jul 2026
- Last update posted
- 12 May 2026
- Registered enrollment
- 175
- Registry id
- NCT03819465
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.